Index of reports
> Life Threatening Events (13)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dantrium (Dantrolene) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Dantrium side effects in female
Reported by a physician from Japan on 2012-08-07
Patient: female
Reactions: Atrioventricular Block Complete
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Dantrium
Other drugs received by patient: Dantrolene Sodium; Diazepam; Recomodulin; Lansoprazole; Unasyn; Omeprazole; Gasmotin
Possible Dantrium side effects in 71 year old male
Reported by a consumer/non-health professional from Netherlands on 2012-04-23
Patient: 71 year old male, weighing 48.0 kg (105.6 pounds)
Reactions: Dyspnoea, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dantrium
Other drugs received by patient: Metformin HCL; Keishikashakuyakudaioutou; Metoprolol Tartrate; Daikentyuto; Rabeprazole Sodium; Kalimate; Magmitt; Cilnidipine; PL Gran.; Tizanidine HCL; Voglibose; Januvia; Aspirin
Possible Dantrium side effects in 50 year old female
Reported by a physician from United States on 2012-04-05
Patient: 50 year old female
Reactions: Off Label Use, Urinary Tract Infection, Acute Myocardial Infarction, Infusion Site Irritation
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dantrium
Possible Dantrium side effects in 71 year old male
Reported by a consumer/non-health professional from Netherlands on 2012-03-28
Patient: 71 year old male
Reactions: Dyspnoea, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dantrium
Other drugs received by patient: Metformin HCL; Metoprolol Tartrate; Keishikashakuyakudaioutou; Aspirin; Rabeprazole Sodium; PL Gran.; Tizanidine HCL; Voglibose; Cilnidipine; Daikentyuto; Januvia; Kalimate; Magmitt
Possible Dantrium side effects in male
Reported by a consumer/non-health professional from Netherlands on 2012-02-13
Patient: male, weighing 77.0 kg (169.4 pounds)
Reactions: Condition Aggravated, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dantrium
Dosage: 50 mg, tid
Administration route: Oral
Indication: Spinal Ligament Ossification
Start date: 2007-04-03
Dantrium
Dosage: 150 mg, daily
Administration route: Oral
Dantrium
Dosage: 75 mg, daily
Administration route: Oral
Other drugs received by patient: Opalmon; Loxonin; Voltaren; Neurotropin; Alendronate Sodium; Adenosine; Tizanidine HCL; Methycobal
Possible Dantrium side effects in
Reported by a physician from United States on 2012-02-10
Patient:
Reactions: Off Label Use, Urinary Tract Infection, Acute Myocardial Infarction, Infusion Site Irritation
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dantrium
Possible Dantrium side effects in male
Reported by a physician from Netherlands on 2012-01-30
Patient: male, weighing 77.0 kg (169.4 pounds)
Reactions: Condition Aggravated, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dantrium
Dosage: 75 mg, daily
Administration route: Oral
Dantrium
Dosage: 50 mg, tid
Administration route: Oral
Indication: Spinal Ligament Ossification
Start date: 2007-04-03
Dantrium
Dosage: 150 mg, daily
Administration route: Oral
Other drugs received by patient: Methycobal; Alendronate Sodium; Tizanidine HCL; Opalmon; Loxonin; Adenosine; Neurotropin; Voltaren
Possible Dantrium side effects in
Reported by a physician from United States on 2012-01-26
Patient:
Reactions: Off Label Use, Urinary Tract Infection, Acute Myocardial Infarction, Infusion Site Irritation
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dantrium
Possible Dantrium side effects in 47 year old female
Reported by a consumer/non-health professional from Netherlands on 2012-01-12
Patient: 47 year old female
Reactions: Mechanical Ventilation, Disturbance in Attention, Brain Oedema, Hyponatraemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Amiodarone HCL
Dosage: 200 mg, daily
Administration route: Oral
Indication: Tachyarrhythmia
Start date: 2009-03-01
Baclofen
Dosage: 25 mg, bid
Administration route: Oral
Indication: Muscle Spasticity
Trimipramine Maleate
Dosage: 25 mg, daily
Administration route: Oral
Indication: Depression
Dantrium
Dosage: 25 mg, tid
Administration route: Oral
Indication: Muscle Spasticity
Other drugs received by patient: Bezafibrat; Marcumar; Propafenone HCL; Trimipramine Maleate; Levodopa; Ferrous Sulfate TAB; SAB Simplex; Dantramacrin; Baclofen
Possible Dantrium side effects in male
Reported by a consumer/non-health professional from Netherlands on 2012-01-06
Patient: male, weighing 77.0 kg (169.4 pounds)
Reactions: Condition Aggravated, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dantrium
Dosage: 50 mg, tid
Administration route: Oral
Indication: Spinal Ligament Ossification
Start date: 2007-04-03
Dantrium
Dosage: 75 mg, daily
Administration route: Oral
Dantrium
Dosage: 150 mg, daily
Administration route: Oral
Other drugs received by patient: Opalmon; Alendronate Sodium; Tizanidine HCL; Adenosine; Neurotropin; Methycobal; Loxonin; Voltaren
Possible Dantrium side effects in 5 year old female
Reported by a physician from Japan on 2012-01-05
Patient: 5 year old female, weighing 9.7 kg (21.3 pounds)
Reactions: Apnoea, Somnolence
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dantrium
Dosage: daily dose: 3 mg
Administration route: Oral
Start date: 2008-06-01
Mystan
Administration route: Oral
Start date: 2009-04-20
Keppra
Dosage: daily dose: 550 mg
Administration route: Oral
Indication: Epilepsy
Start date: 2011-01-01
Keppra
Administration route: Oral
Start date: 2011-05-23
End date: 2011-06-05
Keppra
Dosage: daily dose: 450 mg
Administration route: Oral
Start date: 2011-11-26
End date: 2011-01-01
Phenobarbital TAB
Dosage: daily dose: 100 mg
Administration route: Oral
Start date: 2008-05-01
Lioresal
Dosage: daily dose: 6 mg
Administration route: Oral
Start date: 2010-10-01
Keppra
Administration route: Oral
Start date: 2011-10-24
End date: 2011-11-25
Keppra
Administration route: Oral
Start date: 2011-05-09
End date: 2011-05-22
Lexotan
Administration route: Oral
Start date: 2009-08-19
Keppra
Administration route: Oral
Start date: 2011-06-06
End date: 2011-10-23
Haloperidol
Dosage: 0.5 mg
Administration route: Oral
Start date: 2008-08-01
Other drugs received by patient: Alinamin-F; Gasmotin; Artane; Mucodyne; Lansoprazole; Neuquinon; Mucosolvan DS FOR Pediatric; Promacta
Possible Dantrium side effects in male
Reported by a physician from Netherlands on 2011-12-23
Patient: male, weighing 77.0 kg (169.4 pounds)
Reactions: Condition Aggravated, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dantrium
Other drugs received by patient: Adenosine; Alendronate Sodium; Tizanidine HCL; Methycobal; Voltaren; Neurotropin; Opalmon; Loxonin
Possible Dantrium side effects in 5 year old female
Reported by a physician from Japan on 2011-12-13
Patient: 5 year old female, weighing 9.7 kg (21.3 pounds)
Reactions: Apnoea, Somnolence
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Keppra
Administration route: Oral
Dantrium
Administration route: Oral
Keppra
Administration route: Oral
Start date: 2011-11-01
End date: 2011-11-01
Lioresal
Mystan
Administration route: Oral
Lexotan
Administration route: Oral
Keppra
Administration route: Oral
Indication: Epilepsy
Start date: 2011-12-01
Phenobarbital TAB
Administration route: Oral
Haloperidol
Dosage: 0.5 mg
Administration route: Oral
|